LCM
SCMP

Laurion Capital Management’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Laurion Capital Management’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-36,300
Closed -$652K – 1901
2017
Q4 		$652K Sell
36,300
-584,828
-94% -$7.2M ﹤0.01% 1079
2017
Q3 		$7.33M Buy
+621,128
New +$6.97M 0.03% 391

Other funds holding SCMP

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Laurion Capital Management's SCMP Position: Q1 2018 in Review

Laurion Capital Management sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 36,300 shares — an estimated $652K sold.

Laurion Capital Management first reported a position in SCMP in Q3 2017 and held it in 2 quarters. The position peaked at $7.33M in Q3 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

  • Laurion Capital Management reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
  • Laurion Capital Management sold 36,300 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $652K.
  • Laurion Capital Management first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2017 and held it in 2 quarters.
  • Laurion Capital Management's Sucampo Pharmaceuticals, Inc. position peaked at $7.33M in Q3 2017.
  • 3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Laurion Capital Management's 13F filing for Q1 2018, filed 14 May 2018.